The invention provides binding molecules that specifically bind to rabies virus and are capable of neutralizing the virus. The invention further provides nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from rabies virus. Preferably, they can be used in the post-exposure prophylaxis of rabies.

 
Web www.patentalert.com

< Dipeptidyl peptidase inhibitors

> Oligonucleotides comprising a modified or non-natural nucleobase

> Tropane derivatives useful in therapy

~ 00541